As of September 2024, Bridge Biotherapeutics has a market cap of $64.18M. This makes Bridge Biotherapeutics the world's 23779th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $44.72M | -15.68% |
2023 | $53.04M | -71.80% |
2022 | $188.10M | -17.96% |
2021 | $229.27M | - |